Taiwan needs to protect research data that looks into new uses for drugs that are no longer covered by patent in line with WTO regulations, biotech experts urged yesterday.
"Patent protection is pivotal, but data protection and exclusivity are also essential," Manuel Campolini, a spokesman for the European Federation of Pharmaceutical Industries and Associations, said at a Taiwan-Europe government-level intellectual property rights (IPR) seminar in Taipei yesterday.
"Taiwan is a highly developed country and it is extremely important that the system in terms of patent and data protection be modeled on the basis of the same system developed in [industrial] countries," Campolini said.
When drugs pass their patent period, their research data is no longer classified. Drug companies can then use the data to create their own version of the drug -- known as a generic -- which can be sold freely in competition with the original drug and other generics.
But if a company researches a new use of the expired drug, its data is protected under the WTO's "Trade Related Aspects of Intellectual Property Agreement."
As researchers exhaust the number of effective chemicals that can treat human ailments, finding new uses for old drugs is becoming increasingly critical. Money spent on research into new applications or variations of old drugs will be wasted if the research is not protected.
"The driving force towards new technology in the drug industry is reworking old drugs that have passed their patent period," said David Silver, director of Biotecheast.com, a Web site that promotes Taiwan's biotechnology and pharmaceutical industries.
Refusal to protect this kind of research could hurt public health, Campolini said, citing the example of a variant of the protein interferon that is now being used to treat the deadly hepatitis C virus.
"If biotechnology research is not protected, do you think investments in new uses of drugs will be made?" he said.
"No, never!" Campolini added.
A Taipei-based legal expert agreed.
"Taiwan is in a position to move in a club with the advanced countries," said John Eastwood, co-chairman of the Intellectual Property Committee of the European Chamber of Commerce Taipei.
"Does Taiwan really want to be a developing country that doesn't respect data protection? Even China offers six years of protection," Eastwood said.
Unfortunately the government has yet to offer a pledge on drug research data protection, Eastwood said. So far Taiwan has no legislation to protect this kind of research, he added.
Among the rows of vibrators, rubber torsos and leather harnesses at a Chinese sex toys exhibition in Shanghai this weekend, the beginnings of an artificial intelligence (AI)-driven shift in the industry quietly pulsed. China manufactures about 70 percent of the world’s sex toys, most of it the “hardware” on display at the fair — whether that be technicolor tentacled dildos or hyper-realistic personalized silicone dolls. Yet smart toys have been rising in popularity for some time. Many major European and US brands already offer tech-enhanced products that can enable long-distance love, monitor well-being and even bring people one step closer to
Malaysia’s leader yesterday announced plans to build a massive semiconductor design park, aiming to boost the Southeast Asian nation’s role in the global chip industry. A prominent player in the semiconductor industry for decades, Malaysia accounts for an estimated 13 percent of global back-end manufacturing, according to German tech giant Bosch. Now it wants to go beyond production and emerge as a chip design powerhouse too, Malaysian Prime Minister Anwar Ibrahim said. “I am pleased to announce the largest IC (integrated circuit) Design Park in Southeast Asia, that will house world-class anchor tenants and collaborate with global companies such as Arm [Holdings PLC],”
Sales in the retail, and food and beverage sectors last month continued to rise, increasing 0.7 percent and 13.6 percent respectively from a year earlier, setting record highs for the month of March, the Ministry of Economic Affairs said yesterday. Sales in the wholesale sector also grew last month by 4.6 annually, mainly due to the business opportunities for emerging applications related to artificial intelligence (AI) and high-performance computing technologies, the ministry said in a report. The ministry forecast that retail, and food and beverage sales this month would retain their growth momentum as the former would benefit from Tomb Sweeping Day
Thousands of parents in Singapore are furious after a Cordlife Group Ltd (康盛人生集團), a major operator of cord blood banks in Asia, irreparably damaged their children’s samples through improper handling, with some now pursuing legal action. The ongoing case, one of the worst to hit the largely untested industry, has renewed concerns over companies marketing themselves to anxious parents with mostly unproven assurances. This has implications across the region, given Cordlife’s operations in Hong Kong, Macau, Indonesia, the Philippines and India. The parents paid for years to have their infants’ cord blood stored, with the understanding that the stem cells they contained